Cite
HARVARD Citation
Arakawa, Y. et al. (n.d.). MBRS-40. HMGA2 IS A PROGNOSTIC FACTOR TO INDUCE MALIGNANT PHENOTYPE IN MEDULLOBLASTOMA. Neuro-oncology. 20 (2), p. i137. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arakawa, Y. et al. (n.d.). MBRS-40. HMGA2 IS A PROGNOSTIC FACTOR TO INDUCE MALIGNANT PHENOTYPE IN MEDULLOBLASTOMA. Neuro-oncology. 20 (2), p. i137. [Online].